Safety profile of docetaxel in older patients with metastatic breast cancer.

被引：0
|
作者：
Aapro, MS
Olsen, SR
Alakl, M
Murawsky, M
Hurria, A
机构：
[1] Clin De Genolier, Genolier, Switzerland
[2] Aventis Pharmaceut, Bridgewater, NJ USA
[3] Aventis Pharmaceut, Antony, France
[4] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2003年 / 82卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
532
引用
收藏
页码：S129 / S129
页数：1
相关论文
共 50 条
  • [1] Docetaxel in older patients for metastatic prostate cancer.
    Mark, Frances May
    Pollard, Adam
    Thomson, Alastair H.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [2] Improvement of safety profile of docetaxel by weekly administration in patients with metastatic breast cancer
    Warm, Mathias
    Nawroth, Frank
    Ohlinger, Ralf
    Valter, Marcus
    Pantke, Ellen
    Mallmann, Peter
    Harbeck, Nadia
    Kates, Ronald
    Thomas, Anke
    ONKOLOGIE, 2007, 30 (8-9): : 436 - 441
  • [3] Safety of eribulin in Korean patients with metastatic breast cancer.
    Park, Yeon Hee
    Im, Young-Hyuck
    Lee, Keun-Seok
    Park, In Hae
    Sohn, Joohyuk
    Lee, Soohyeon
    Kim, Tae Yong
    Im, Seock-Ah
    Kim, Jee Hyun
    Kim, Se Hyun
    Lee, Soo Jung
    Koh, Su-Jin
    Lee, Ki Hyeong
    Choi, Yoon Ji
    Cho, Eun Kyung
    Lee, Suee
    Kang, Seok Yun
    Seo, Jae Hong
    Kim, Sung-Bae
    Jung, Kyung Hae
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [4] Activity and safety of biweekly docetaxel plus capecitabine as first-line treatment for patients with metastatic breast cancer.
    Llorca, C
    Mayordomo, J
    Adrover, E
    Alvarez, I
    Madroñal, C
    Burillo, M
    Sanz, J
    Lorenzo, A
    Palombo, H
    Janariz, J
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 73S - 73S
  • [5] ASSESSMENT OF SAFETY PROFILE OF TRASTUZUMAB IN METASTATIC BREAST CANCER PATIENTS
    Rana, C.
    Mann, K.
    Wadhwa, A.
    VALUE IN HEALTH, 2011, 14 (03) : A158 - A158
  • [6] Phase II evaluation of liposomal doxorubicin combined with docetaxel in patients with metastatic breast cancer.
    Uldrick, T
    Crew, K
    Tiersten, A
    Braffman, L
    Blozie, K
    Hershman, D
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 104S - 104S
  • [7] A phase 2 study of docetaxel in combination with indoximod in metastatic breast cancer.
    Soliman, Hatem Hussein
    Minton, Susan E.
    Ismail-Khan, Roohi
    Han, Hyo S.
    Vahanlan, Nicholas N.
    Ramsey, William Jay
    Kennedy, Eugene
    Link, Charles J.
    Sullivan, Daniel
    Antonia, Scott Joseph
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [8] A phase II study of capecitabine and weekly docetaxel combination chemotherapy in patients with metastatic breast cancer.
    Puglisi, F
    Scalone, S
    Minisini, AM
    Mansutti, M
    Crivellari, D
    Buonadonna, A
    Zanetti, M
    Ermacora, P
    Piga, A
    Veronesi, A
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 78S - 78S
  • [9] A phase II study of weekly or 3-weekly docetaxel in patients with metastatic breast cancer.
    Grecea, D
    Tanasescu, R
    Vasiliniuc, C
    Neamtiu, L
    Ghilezan, N
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 62S - 62S
  • [10] A review of the efficacy and safety of docetaxel as monotherapy in metastatic breast cancer
    Crown, J
    SEMINARS IN ONCOLOGY, 1999, 26 (01) : 5 - 9
12345